Aromatase inhibitors vs placebo
Severe toxicity · women with above‐average risk of developing breast cancer
Aromatase inhibitors leads to higher severe toxicity compared with placebo (high certainty).
1 finding from 1 review
- Risk‐reducing medications for primary breast cancer: a network meta‐analysis 2019 · Cochrane Headline outcomes onlyRR 1.18 [1.09, 1.28]2 studies · 8352 participantsHigh